Case 35-2004: A 68-year-old man with end-stage renal disease and thickening of the skin

New England Journal of Medicine

Volumn 351, Issue 21, 2004, Pages 2219-2227

  Moschella, Samuel L ^a,c   Kay, Jonathan ^b,c   Mackool, Bonnie T ^b,c   Liu, Vincent ^b,c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ATENOLOL; ATORVASTATIN; DOCUSATE SODIUM; ESOMEPRAZOLE; EYE DROPS; GABAPENTIN; GLOBULIN; HEPARIN; INSULIN; ISOSORBIDE MONONITRATE; NIFEDIPINE; PREDNISOLONE; VITAMIN B COMPLEX; WARFARIN;

ABDOMINAL PAIN; AGED; ARM; ARTICLE; BLINDNESS; BLOOD ANALYSIS; BYPASS SURGERY; CASE REPORT; CONNECTIVE TISSUE DISEASE; CORONARY ARTERY DISEASE; DIABETIC NEUROPATHY; DIARRHEA; DUODENOSCOPY; EPIGASTRIC PAIN; EROSIVE GASTRITIS; ESOPHAGITIS; ESOPHAGUS ULCER; FALLING; FOOT ULCER; GAIT DISORDER; HEARTBURN; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERTENSION; INDIGESTION; JOINT CONTRACTURE; KIDNEY FAILURE; LEG; LEG PAIN; LIPODERMATOSCLEROSIS; LIQUID; LUNG EDEMA; MALE; MEDICAL SPECIALIST; MUSCLE WEAKNESS; NEPHROGENIC FIBROSING DERMOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; POLYNEUROPATHY; PRIORITY JOURNAL; RETINOPATHY; SKIN BIOPSY; SKIN DISEASE; SKIN FIBROSIS; SKINFOLD; STOMACH HEMORRHAGE; THORAX PAIN; THORAX RADIOGRAPHY; UPPER GASTROINTESTINAL BLEEDING; WALKING AID; BIOPSY; CHRONIC KIDNEY FAILURE; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; EOSINOPHILIA MYALGIA SYNDROME; FIBROSIS; PATHOLOGY; SKIN;

AGED; BIOPSY; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA-MYALGIA SYNDROME; FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; SKIN; SKIN DISEASES;

EID: 16544384936     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc049026     Document Type: Article

References (28)

1. Robinson-Bostom L, DiGiovanna JJ. Cutaneous manifestations of end-stage renal disease. J Am Acad Dermatol 2000;43:975-86.
2. Huntley AC. Cutaneous manifestations of diabetes mellitus. Dermatol Clin 1989;7:531-46.
3. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 1993;28:623-7.
4. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, Leboit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000;356:1000-1.
5. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001;23:383-93.
6. Ting WW, Stone MS, Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003;139:903-6.
7. Fibrosing skin condition among patients with renal disease - United States and Europe, 1997-2002. MMWR Morb Mortal Wkly Rep 2002;51:25-6.
8. Mackay-Wiggan JM, Cohen DJ, Hardy MA, Knobler EH, Grossman ME. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 2003;48:55-60.
9. Hubbard V, Davenport HV, Jarmulowicz M, Rustin M. Scleromyxoedema-lilce changes in four renal dialysis patients. Br J Dermatol 2003;148:563-8.
10. LeBoit PE. What nephrogenic fibrosing dermopathy might be. Arch Dermatol 2003;139:928-30.
11. Streams BN, Liu V, Liegeois N, Moschella SM. Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. J Am Acad Dermatol 2003;48:42-7.
12. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001;44:273-81.
13. Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995;33:37-43.
14. Jablonska S, Rodnan GP. Localized forms of scleroderma. Clin Rheum Dis 1979;5:215-41.
15. Perez MI, Kohn SR. Systemic sclerosis. J Am Acad Dermatol 1993;28:525-47.
16. Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17:221-31.
17. Varga J, Heiman-Patterson TD, Emery DL, et al. Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome. Semin Arthritis Rheum 1990;19:313-28.
18. Hertzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990;322:869-73.
19. Romas E, Finlay M, Woodruff T. The arthropathy of fibroblastic rheumatism. Arthritis Rheum 1997;40:183-7.
20. Baron M, Lee P, Keystone EC. The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis 1982;41:147-52.
21. Kane-Wanger G, Ostrov BE, Freundlich B. Knee contractures as the presenting manifestation of scleroderma. Ann Rheum Dis 1992;51:810-1.
22. Palmer DG, Hale GM, Grennan DM, Pollock M. Bowed fingers: a helpful sign in the early diagnosis of systemic sclerosis. J Rheumatol 1981;8:266-72.
23. 2-Microglobulin amyloidosis. Int J Exp Clin Invest 1997;4:187-211.
24. Kapoor A, Sibbitt WL Jr. Contractures in diabetes mellitus: the syndrome of limited joint mobility. Semin Arthritis Rheum 1989;18:168-80.
25. Seibold JR. Digital sclerosis in children with insulin-dependent diabetes mellitus. Arthritis Rheum 1982;25:1357-61.
26. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med 2002;112:487-90.
27. D'Amato RJ, Loughnan MS, Flynn E, Polkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 1994;91:4082-5.
28. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991;173:699-703.